Operating Income: The income after operating expenses.
10x Genomics (TXG) had Operating Income of $-16.06M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$150.67M |
|
$-19.43M |
|
$37.74M |
|
$112.93M |
|
$166.72M |
|
|
Operating Income |
$-16.06M |
$-2.42M |
|
$-18.48M |
|
$-18.48M |
|
$-19.43M |
|
$-19.43M |
|
$-19.43M |
|
$-19.43M |
|
$-16.06M |
|
$-4.45M |
|
130.81M |
|
130.81M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$718.63M |
|
$210.24M |
|
$344.50M |
|
$1.06B |
|
$140.37M |
|
-- |
|
$84.72M |
|
$225.09M |
|
$838.04M |
|
$772.46M |
|
$838.04M |
|
131.53M |
|
| Cash Flow Statement Financials | |
$58.93M |
|
$-9.55M |
|
$3.12M |
|
$473.97M |
|
$526.19M |
|
$52.22M |
|
$71.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.12 |
|
-- |
|
-- |
|
-- |
|
-- |
|
74.95% |
|
-10.66% |
|
-10.66% |
|
-- |
|
-12.26% |
|
-12.89% |
|
$54.77M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.58 |
|
2.56 |
|
35.10 |
|
-2.32% |
|
-2.51% |
|
-1.83% |
|
-2.32% |
|
$6.37 |
|
$0.42 |
|
$0.45 |
|